Posted on April 27th, 2012 by Health News
InDex Pharmaceuticals today announced that it has been granted a patent by the United States Patent and Trademark Office. The patent provides additional protection for the use of Kappaproct® and additional DNA-based immunomodulatory sequences (DIMS) for the treatment of steroid-resistant inflammatory diseases including inflammatory bowel disease, rheumatoid arthritis, psoriasis, asthma, emphysema and chronic obstructive [...]
No Comments »
Filed under: Pharmacy News
Posted on April 17th, 2012 by Health News
To relieve pain, arthritis sufferers are prescribed medications that may include non-steroidal anti-inflammatory drugs (NSAIDs) or cyclooxygenase-2 (COX-2) inhibitors, both of which can irritate the digestive tract. At times additional drugs are co-prescribed with NSAIDs or COX-2 inhibitors to prevent adverse gastrointestinal (GI) effects.
No Comments »
Filed under: Pharmacy News
Posted on April 3rd, 2012 by Health News
A trend toward more aggressive treatment in patients just starting to develop rheumatoid arthritis is among the most important changes in treatment guidelines for the disease, according to updated American College of Rheumatology recommendations published today in the journal Arthritis Care & Research. The trend may proceed from emerging opinions that joint damage caused by [...]
No Comments »
Filed under: Pharmacy News
Posted on March 29th, 2012 by Health News
Oral glucocorticoids are commonly prescribed for a wide variety of disorders, most commonly for rheumatoid arthritis, obstructive pulmonary disease and inflammatory bowel diseases. However, the use of these medications can result in rapid bone loss during the first three to six months of therapy, leading to increased risk of fragility fractures.
No Comments »
Filed under: Pharmacy News
Posted on March 29th, 2012 by Health News
Millions of people around the world are prescribed glucocorticoids for a wide variety of inflammatory conditions, including, rheumatoid arthritis, asthma and inflammatory bowel diseases. Although they are effective and widely used, one of the potentially serious side effects of these medications is glucocorticoid-induced osteoporosis.
No Comments »
Filed under: Pharmacy News
Posted on March 14th, 2012 by Health News
A panel of experts for the U.S. Food and Drugs Administration (FDA) this Monday recommended that the federal government should allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure.
No Comments »
Filed under: Pharmacy News
Posted on March 13th, 2012 by Health News
A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.
No Comments »
Filed under: Pharmacy News
Posted on March 2nd, 2012 by Health News
Glucocorticoids, which are widely used to treat asthma, rheumatoid arthritis, and other autoimmune diseases, have been linked to a significant risk for suicide, mania, delirium, and depression. Medscape Medical News
No Comments »
Filed under: General Health News
Posted on February 21st, 2012 by Health News
A multi-center study of a national survey published in Arthritis Care and Research, a journal of the American College of Rheumatology (ACR), has established that over half of women with rheumatoid arthritis (RA) and systematic lupus erythematosus (SLE) have fewer children than desired. Leading researcher, Kaleb Michaud, Ph.D…
No Comments »
Filed under: Women's Health
Posted on February 13th, 2012 by Health News
A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease.
No Comments »
Filed under: Pharmacy News
